About this trial
Sexual health is a vital component of gynecologic cancer treatment and survivorship. Unfortunately, most gynecologic cancer survivors lack sufficient information about the impact of cancer on sexual health and treatment opportunities. This research aims to assess how well an adapted online health intervention meets the sexual health needs of gynecologic cancer survivors and to test the efficacy of the new platform. If successful, eSense-Cancer may increase access to treatment for gynecologic cancer survivors, including those living in remote areas or facing other accessibility barriers. It may also fill healthcare gaps for survivors of varying ethnicity, sexual orientation, socioeconomic status, and gender.
Eligibility criteria
Qualifiers
self-report a current or history of gynecologic cancer of any subtype
self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised
are fluent in English (eSense content is delivered in English)
have reliable internet access and basic competency in using online platforms (individuals will self-report)
Disqualifiers
have visual impairments or disabilities interfering with reading and ability to interact with online materials
have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening)
individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).
Trial design
Treatments tested in this trial
- eSense-Cancer CBT: an online cognitive-behavioural therapy based intervention for sexual health concerns after gynecologic cancer
- Navigator support for eSense-Cancer
- Behavioral: eSense-Cancer MBT: an online cognitive-behavioural therapy based intervention for sexual health concerns after gynecologic cancer
Treatment groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
Xavier University of Louisiana.
Collaborator